Results 31 to 40 of about 42,255 (232)
Российский кардиологический журнал, 2019 Aim. To identify the effect of preprocedural laboratory parameters on the occurrence of in-stent restenosis in various types of stents, to assess the significance of gender, age and various forms of coronary artery disease (CAD) as risk factors for ...
D. V. Shames +3 more
doaj +1 more source
Dealing with in-stent restenosis [PDF]
Heart, 1998 Stents have been shown to reduce the incidence of restenosis; however, they are not a cure. In two trials the angiographic restenosis rate was reported to be between 20% and 30% (in the Benestent II trial the unpublished quoted restenosis rate was 15%). These trials were based on stenting short, de novo lesions, in native coronary arteries.
A H, Gershlick, J, Baron
openaire +2 more sources
Clinical evaluation of radioactive stents [PDF]
, 2001 Restenosis, the major problem after stent implantation, is caused by in-stent neointimal hyperplasia. A number of metbods and techniques have been studied during the last ten years to address tbis issue, but in-stent restenosis has remained at a rate of ...
Wardeh, A.J. (Alexander)
core +14 more sources
Majalah Kardiologi IndonesiaBackground: Despite the fact that DES implantation has decreased theincidence of ISR dramatically, it is not negligible. Diffuse ISR is associated withpoor outcomes.
Ahmed Mahmoud El Amrawy +2 more
doaj +1 more source
SAGE Open Medical Case Reports, 2021 In recent years, various devices have been approved for peripheral artery disease with femoropopliteal lesions. However, treatment of long, calcified, and diffused lesions is still challenging because these lesions are associated with restenosis.
Naoki Yoshioka +4 more
doaj +1 more source
Predictors of In-Stent Restenosis [PDF]
Angiology, 2018 Abstract Not ...
Mehmet Kadri Akboga, Samet Yilmaz
openaire +4 more sources
Journal of Interventional Cardiology, 2001 Stent restenosis, especially the diffuse pattern, has developed into a significant clinical and economical problem. It has been estimated that up to 250,000 patients developed in‐stent restenosis in 2,000 alone, two thirds of them can be expected to have diffuse in‐stent restenosis, which is difficult to treat because of high recurrence rates.
openaire +2 more sources
Emotions and scope effects in the monetary valuation of health [PDF]
, 2018 JEL classifications: H41 H51 I11 I18 I31This study presents evidence on the role of emotions in the monetary evaluation of health technologies, namely, drug-eluting stents (DES) in our case.
Araña, Jorge +3 more
core +1 more source
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching [PDF]
, 2012 Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial.
Angelo Guglielmotti +12 more
core +3 more sources
A novel ultrafast-low-dose computed tomography protocol allows concomitant coronary artery evaluation and lung cancer screening [PDF]
, 2018 BACKGROUND:Cardiac computed tomography (CT) is often performed in patients who are at high risk for lung cancer in whom screening is currently recommended.
Bandiera, A +10 more
core +1 more source